Safety of Nivolumab Plus Low‐Dose Ipilimumab in Previously Treated Microsatellite Instability‐High/Mismatch Repair‐Deficient Metastatic Colorectal Cancer
Oncologist - United States
doi 10.1634/theoncologist.2019-0129
Full Text
Open PDFAbstract
Available in full text
Date
May 30, 2019
Authors
Publisher
Alphamed Press